Bristol-Myers Squibb Company (BMY): Price and Financial Metrics
Bristol-Myers Squibb Company (BMY)
Today's Latest Price: $66.74 USD
Updated Jan 19 7:00pm
Add BMY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 239 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
BMY Stock Summary
- BMY has a higher market value than 98.67% of US stocks; more precisely, its current market capitalization is $150,363,866,008.
- BMY's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 7,142.73 -- higher than 99.57% of US-listed equities with positive expected earnings growth.
- The volatility of Bristol Myers Squibb Co's share price is greater than that of just 0.41% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to Bristol Myers Squibb Co are DDOG, TRUP, SYY, SBAC, and AMK.
- Visit BMY's SEC page to see the company's official filings. To visit the company's web site, go to www.bms.com.
BMY Stock Price Chart Interactive Chart >
BMY Price/Volume Stats
| Current price | $66.74 | 52-week high | $68.34 |
| Prev. close | $66.54 | 52-week low | $45.76 |
| Day low | $66.32 | Volume | 10,847,800 |
| Day high | $67.16 | Avg. volume | 12,391,618 |
| 50-day MA | $62.67 | Dividend yield | 2.95% |
| 200-day MA | $60.75 | Market Cap | 151.01B |
Bristol-Myers Squibb Company (BMY) Company Bio
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, including virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular. The company was founded in 1887 and is based in New York, New York.
Loading social stream, please wait...